Loading…
← CockpitCompetitor Analysis › 2905.TW Mercuries & Associates, Holding Ltd.Open in the cockpit ↗

Mercuries & Associates, Holding Ltd.2905.TWCompetitor analysis, valuation and peers

Taiwan · TWD·Financials›Life/Health Insurance
Momentum leader 89
Mkt cap
$561M
US dollars, full cap
Free float
59%
of shares outstanding
$/day
$790,183
20-day average traded
P/B
0.22×
price to book
ROE
5.1%
delivered
Implied ROE
1.8%
what the price asks
Close · TWDNT$17.45
1D-2.5%
1W-3.3%
1M-1.1%
3M+6.7%
6M+29.7%
YTD+10.1%
1Y+39.0%
ATR %2.6%
52w lowhigh8.2% off high

What Mercuries & Associates does

No business profile yet.

Mercuries & Associates at a glance

Size Mercuries & Associates (2905.TW) is a Taiwan Financials company (Life/Health Insurance) with a market value of $561M, the 413th largest of 687 Taiwan companies the cockpit tracks. Shares closed at NT$17.45 on 6 Nov 2026.

Performance Over six months the shares gained 29.7%, against -10.5% for the median peer and -3.4% for the Taiwan market (cap-weighted) — highest of 9 in its peer set.

Growth Revenue fell 5.9% over the last twelve months (peer median +17.5%); the operating margin is -14.3% (peer median 3.9%).

Valuation It trades at 0.22× book value against a peer median of 1.11× (cheapest of 9).

Price implies The share price implies a return on equity of about 1.8%; Mercuries & Associates delivers 5.1%, so the price asks less than the business earns today.

Relative performance

10012014011 May 202611 Aug 20266 Nov 20262905.TW 129Peer median 90
Six months, rebased to 100: Mercuries & Associates against the median of its 8 peers (local-currency closes).

Mercuries & Associates financials

Reported figures in TWD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueNT$140BNT$156BNT$115BNT$145BNT$83.3B
Revenue growth—+36%-21%+74%—
Net incomeNT$2.86BNT$755MNT$1.52B-NT$2.87B-NT$5.09B
Free cash flow-NT$1.52BNT$11.2BNT$13.2BNT$5.14BNT$16.1B
Capital expenditureNT$2.00BNT$2.24BNT$3.45BNT$1.99BNT$3.05B
Total debtNT$46.8BNT$45.1BNT$27.4BNT$23.8BNT$25.8B

Quarterly statements and history in the cockpit →

Mercuries & Associates competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-20%0%+20%-20%-10%0%585971570376CANHLIFENIVABUPANBG60856200883502905.TW6-month return →1-month return →
Up and to the right = strong over both horizons. Mercuries & Associates is the large dot.

Fundamentals: return on equity against price-to-book

5%7.5%10%12.5%00×20×40×60×585971570376CANHLIFENIVABUPANBG60856200883502905.TWReturn on equity →Price / book →
A bank or insurer earning more on its equity usually trades at a higher multiple of book; points far above the trend are priced for more. Mercuries & Associates is the large dot.

Capital: ROE delivered against the ROE the price implies

0%20%40%0%20%40%585971570376CANHLIFENIVABUPA2905.TWROE delivered →ROE the price implies →
Above the diagonal = the price asks for a higher return on equity than the business earns today. Mercuries & Associates is the large dot.

Mercuries & Associates competitors and peer comparison

How Mercuries & Associates compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Mercuries & Associates against its 8 peers (data as of 6 Nov 2026)
Measure2905.TWPeer medianRank in peer set
1-month return-1.1%-4.6%2nd highest of 9
6-month return+29.7%-10.5%highest of 9
Return on equity5.1%7.4%2nd lowest of 9
Price / book0.22×1.11×cheapest of 9
Trailing P/E6.5×17.0×3rd cheapest of 9
ROE the price implies1.8%6.5%2nd least demanding of 9
ROE delivered5.1%7.4%2nd lowest of 9

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthROEPrice / bookImplied ROEDelivered ROE
Mercuries & Associates 2905.TWTaiwan$561M+30%-6%5%0.22×1.8%5.1%
Farglory Life Insurance 5859.TWOTaiwan$625M-7%-48%7%0.23×1.7%7.1%
Lifenet Insurance 7157.TJapan$710M-28%+12%8%1.18×7.0%7.9%
Yunfeng Financial 0376.HKHong Kong$999M-30%+21%7%0.60×7.8%6.7%
Canara HSBC Life Insurance CANHLIFE.NSIndia$1.23B-14%+17%8%7.08×48.0%8.2%
Niva Bupa Health Insurance NIVABUPA.NSIndia$1.49B-5%+58%14%3.66×33.1%13.9%
Nuernberger Beteiligungs NBG6.DEGermany$1.58B+1%-1%5%1.58×6.0%5.1%
Mirae Asset Life Insurance 085620.KSSouth Korea$1.78B+17%+22%5%1.05×5.6%5.2%
Hanwha Life 088350.KSSouth Korea$2.16B-20%+18%8%0.22×3.8%7.7%

Questions

Which companies are Mercuries & Associates's closest peers?
The cockpit's peer set: Farglory Life Insurance (5859.TWO), Lifenet Insurance (7157.T), Yunfeng Financial (0376.HK), Canara HSBC Life Insurance (CANHLIFE.NS), Niva Bupa Health Insurance (NIVABUPA.NS), Nuernberger Beteiligungs (NBG6.DE), Mirae Asset Life Insurance (085620.KS), Hanwha Life (088350.KS).
Is Mercuries & Associates expensive compared with its peers?
On price / book it trades at 0.22× against a peer median of 1.11×, cheapest of 9 in its peer set. The share price implies a return on equity of about 1.8%; Mercuries & Associates delivers 5.1%, so the price asks less than the business earns today.
How has Mercuries & Associates stock performed?
Over six months to 6 Nov 2026 the shares returned +29.7% against -10.5% for the median peer; over one year +39.0%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.